June 3 at 8am: Shilpa Gupta will present this study on EV+P vs PBC in la/mUC patients at #ASCO24 !

EV+P nearly doubled median PFS and OS, with no detriment to QoL

Compliance rates highlight the need for further research

meetings.asco.org/2024-asco-annu…

Cabozantinib combined with nivolumab in patients with metastatic non-clear cell renal cell carcinoma

⭕️The objective response rate (ORR) was 48%
⭕️Median progression-free survival was 13 months
⭕️Median overall survival was 28 months.
⭕️Comparable results with KEYNOTE-B61,

Felicidades Uromigos Brian Rini, MD Tom Powles
on your expansion Tres Uramigas

Sumanta K. Pal, MD, FASCO Petros Grivas Neeraj Agarwal, MD, FASCO Toni Choueiri, MD
👏👏👇👇

Tremendously enjoyed this podcast as the clip shows 🤓 Thank you for the hospitality and fun conversations during my recent Canada trip and now podcast. Jeffrey Graham jc Andy Hahn Petros Grivas Neeraj Agarwal, MD, FASCO Daniel Shapiro Sumanta K. Pal, MD, FASCO Amanda Nizam, MD Daniel Heng Bora Lim, MD

Honored & humbled to present the PROs from EV-302 of EV-P vs plat in mUC ASCO #ASCO24 Mon, Jun 3, 8 AM session co-chaired by Maite Bourlon Suzanne Cole, MD

Tom Powles Umang Swami Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO Michiel van der Heijden ylt Uromigos Cleveland Clinic MD

Paolo Tarantino Dipesh Uprety MD FACP Mike Thompson, MD, PhD, FASCO Tarek Haykal, MD, MHS Toni Choueiri, MD #3 T-4 #ASCO24 , adding some more lists here to 🤓, this time from the amazing OncoAlert team across different disciplines.. #lcsm #bcsm #pcsm #blcsm #kcsm
Also a great rundown of #lcsm from Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ here: x.com/apassaromd/sta…

At #ASCO24 - an incredibly impt topic being addressed by Rachna Shroff, MD, MS, FASCO & colleagues on June 3 at 10:45 am in E450a. Looking across 5y of ASCO & #GIASCO symposia, they identify significant gaps in M v F abstract presenters & the difference is quite staggering (ASCO 76% vs 24%,

LONG POST ALERT: I wanted to spotlight Jasnoor Malhotra, a 1st yr med student at SLU Medicine. She spent 2y at City of Hope w me prior this doing #clinicalresearch . Beyond the many publications & presentations she drove during her time with me, she made REAL conections with pts in my

Dear Colleagues,
The OncoAlert 🚨Network Presents OUR Picks of
TOP 🔟Abstracts to be Presented at #ASCO24 for #ProstateCancer

This List Curated by:
#OncoAlertAF Leads :
Emre Yekedüz 🇺🇸 Dra. María Natalia Gandur Quiroga 🇦🇷
Gil Morgan, MD 🇺🇸
Distinguished faculty
Toni Choueiri, MD 🇺🇸

Get practical guidance on using ADCs in individualized care of patients with #BladderCancer in an event featuring Petros Grivas, Tian Zhang, MD, MHS, & Evan Y. Yu, MD. Produced with our partner Bladder Cancer Advocacy Network. 6/1 at 6:30 PM CDT: bit.ly/2024ADCBladderT #ASCO24 #MedEd

Oral Ab#1514 ASCO #ASCO24 by Cristiane D Bergerot 👉tinyurl.com/9jte9v4y👉RCT trial of geriatric assessment+supportive intervention (GAIN-S) vs usual care in older pts w cancer👉GAIN-S improved emotional well-being, functional status, & QoL👇William Dale, MD, PhD, FASCO OncoAlert Congrats Cris

Outstanding initiative from Neeraj Agarwal, MD, FASCO who is doing great stuff with the #ASCODailyNews ASCO #ASCO24 OncoAlert

#ASCO24 - While we peruse abstracts, take the time to bookmark education sessions:
🔖 'Treating Lung Cancer in Young Adults: Considerations and Outcomes'
📍Jun 3, Arie Crown, 1130 CDT
Laura Mezquita Matteo Lambertini, MD PhD
ASCO #LCSM

Just in👉Our official ASCO #ASCODailyNews Podcast highlighting some GU abstracts from #ASCO24 👉 you can listen or read the transcript 👉Open access link to all across the world 👉 brnw.ch/21wK9q4 OncoAlert UroToday.com KidneyCAN PCF Science Bladder Cancer Advocacy Network

Just in👉Our official ASCO #ASCODailyNews Podcast highlighting some GU abstracts from #ASCO24 👉 you can listen or read the transcript 👉Open access link to all across the world 👉 brnw.ch/21wK9q4 OncoAlert UroToday.com KidneyCAN PCF Science Bladder Cancer Advocacy Network

Are you Preparing for #ASCO24 ? Learn from your colleagues. Top Abstract recommendations from leaders in Hematology and Oncology:
👉beta.kolpulse.com/public/1409290…
Try out the KOL Pulse AI Chatbot to search for specific recommended abstracts of interest
👉beta.kolpulse.com/public/kolpuls…
KOL

Save the Date: Urology Cancer Summit

Join us in Portsmouth, UK, on September 27, 2024, for the Second International Urology Cancer Summit. Register free and submit abstracts by June 30, 2024. #UrologyCancerSummit #CancerResearch
OncoAlert ONCOassist® | The go-to oncology app

🚨🚨🔥🔥OncoAlert

Alerting colleagues, #Oncologists & #Trainees with interest in #MedicalEducation to JOIN US at the:

✅Annual meeting of ASCO OncMedEdCoP ( #MedEd #CommunityOfPractice ) ASCO during #ASCO24 on:

⏰Sat June 1st at 7:30
📍Room: S103

PLZ SHARE & SPREAD THE WORD
👇🏼

Congrats to Petros Grivas and team for this Clinical Cancer Research paper characterizing a novel FGFR inhibitor. Groundbreaking work indeed. Sumanta K. Pal, MD, FASCO Shilpa Gupta Thomas Flaig Tom Powles Amanda Nizam, MD Vadim Koshkin MD Enrique Grande

Congrats to Petros Grivas Fred Hutchinson Cancer Center & colleagues for a terrific paper out now in Clinical Cancer Research. A massive effort to characterize the activity of #Debio1347 , a novel FGFR inhibitor. 63 pts enrolled in total with a RR of 5%; 45% w SD. Lots of rich information in this paper w rich